用户名:  密码:   
美国华裔教授专家网留言簿
博客导航 — 美国华裔教授专家网>博客留言簿
关键字  范围   
全部留言读者评论个人留言
共12602条留言,每页10条,当前第27/1261页
【首页】【前页】[21] [22] [23] [24] [25] [26] [27] [28] [29] [30] 【后页】【末页】
第  页  
GCKE2019 留言于2019-03-28 17:10:36
评论:UPDATE - From The Chinese American Professors and Professionals Network (2019 No.7)
Dear Dr. Zhenying Jiang

It is our great pleasure to welcome you to join in the 6th Annual Global Congress of Knowledge Economy-2019 (GCKE-2019), which will be held atQingdao International Conference Center, Qingdao, China during September 20-22, 2019. On behalf of the organizing committee, we cordially welcome you to give an oral presentation on your recent research. Your prompt reply with a speech proposal will be highly appreciated.

Hosted by China Council for the Promotion of International Trade, Qingdao Sub-Council, the GCKE congress has successfully attracted more than 3,000 world renowned speakers and participants from more than 40 countries and areas around the world as a leading international event for economy community with 5 years’persistent efforts.

With the theme of “Disruptive Innovation, Powerful Fortune, Leaping Development”, GCKE-2019 will shoot for300 participants from more than 30 countries gather in beautiful Qingdao. The three-day conference comprises many professional programs including Nobel Laureate Forum, Disruptive Innovation Forum, Parallel Sessions on Global Congress of Knowledge Economy, Dialogue, EXPO and Posters, Cultural and Social Activities. For more information, please visit the conference website at: http://www.bitcongress.com/gcke2019/

The venue of the congress is Qingdao International Conference Center, which is the main venue of the Shanghai Cooperation Organization (SCO) Qingdao summit. With an area of 250,000 square meters, it currently remains the largest museum for exhibition and convention purposes in Shandong province.

Qingdao (Tsingtao), is a beautiful seaside city with clear air and enchanting sea view. Autumn is the most pleasant season for a visit. Just walking on the sand and listening to the surf breaking on the beach becomes enjoyable.Qingdaois well known for its own brand of delicious beer, as one of three brands recognized by beer lovers over the world, Tsingtao beer win plaudits at home and abroad because of the pleasant aroma and well-balanced taste.

We are exceedingly proud and delighted to welcome you to Qingdao, China to join our useful and stimulating congress. Looking forward to your positive reply.
Sincerely yours,

Dr. Xiaodan Mei
Executive Chair of GCKE-2019
Organizing Committee of Global Congress of Knowledge Economy 2019
jennifer@gcke2019.com
编辑读者评论
商洛学院人事处 留言于2019-03-28 16:03:17
评论:UPDATE - From The Chinese American Professors and Professionals Network (2019 No.7)
敬爱的美国华裔教授专家网
您好!我们是国内陕西商洛学院人事处。商洛学院是教育部批准、陕西省政府举办的全日制普通本科院校,学校秉承“自强不息 止于至善”的大学精神、坚持“立足商洛,面向地方,建设多学科协调发展的应用型本科院校”的办学定位,建校40年来,为社会培养了4万余名合格人才,为促进区域经济社会发展做出了重要贡献。

当前,学校正在全面贯彻习近平新时代中国特色社会主义思想和党的十九大精神,认真落实陕西省“五新战略”和“四个一流”实施意见,全面加快改革发展。为把学院建成一流应用型本科院校!我院正式对外公开引进高层次人才,因此与您取得联系,希望在建成一流应用型本科院校的道路上能够得到您的大力帮助,将我校此次的人才计划刊登至您这边的相关渠道宣传,引进人才来我院共同发展,实现建成国内一流院校!

用好现有人才,培养更多高层次人才,吸引优秀国际人才,把握人才使用规律,让人才和智力“活”起来。问渠那得清如许,为有源头活水来,培养源源不断的人才和可靠的接班人是建设社会主义现代化强国的关键所在,习近平总书记在全国组织工作会议上针对人才指出,世界各国都在抢抓机遇,国际人才争夺日趋白热化。商洛学院比任何时期都急需人才,必须加快实施扩建人才师资队伍,确立人才引领发展的战略地位,努力建设成奉献祖国、献教育、勇于创新创造、助力高水平人才培养的国内一流院校!

学院在此次人才引进待遇中将采取一人一议,一事一议的办法协商相关待遇、相信在您的帮助下商洛学院会不断进步且成为一流院校。感谢您的支持及帮助!
最真心的祝愿。

商洛学院人事处
电话:0914—2252871
slxyrsc@126.com
编辑读者评论
楊州大学人事处 留言于2019-03-27 16:12:38
评论:UPDATE - From The Chinese American Professors and Professionals Network (2019 No.7)
美国华裔教授专家网
冒昧打扰,请您谅解。因工作需求特联系您希望得到您的帮助。

为大力推进“人才强校”战略,加快建设“国内一流、国际知名、特色鲜明的高水平研究型大学”的进程,现面向海内外招聘相关专业人才,因此特别与您联系,敬请您帮助将扬州大学人才招聘启事上网宣传,借贵处的力量让在外华人查阅到扬州大学人才引进公告,欢迎海外学者来我校实地走访,亲身感受扬州大学急需人才的渴望。

万分感谢!
楊州大学人事处
yzu_rsk@163.com
0514-87971876
编辑读者评论
北京协和医学院 留言于2019-03-27 15:58:32
评论:UPDATE - From The Chinese American Professors and Professionals Network (2019 No.7)
北京协和医学院4+4临床试点班招生
北京东单九号院,是著名的北京协和医学院的所在地。百年来,从这里毕业的莘莘学子,已成为中国医学界的脊梁。现在,他们又汇集在这里,为每一位中国老百姓,用平实简单的语言,做负责任的医学科普。

经教育部批准,北京协和医学院临床医学专业试点班从2019 年起除继续从国内高水平大学招收推免生以外,同时面向国内外高水平大学招收优秀本科毕业生直接攻读博士学位。试点班招生简章已经正式上线,欢迎您访问!

请感兴趣的同学仔细阅读招生简章、入学课程要求和报名流程,并请于2019年3月1日至4月10日之间登录试点班招生网站,在线注册并填写报名申请表。(http://mdadmission.pumc.edu.cn
联系邮箱:pumcalumini@163.com
编辑读者评论
Barstow College 留言于2019-03-27 01:40:11
评论:UPDATE - From The Chinese American Professors and Professionals Network (2019 No.7)
Hello,
Please review the link below and forward to anyone interested in applying. The current job vacancies with Barstow College are:

CLASSIFIED:
Database Analyst

CERTIFICATED:
Athletic Director/Faculty (70/30)
Mental Health Counselor – Grant Funded

MANAGEMENT:
Dean of Instruction
Director, Public Relations, Communications and Marketing
Vice President, Academic Affairs
Vice President, Administrative Services
Vice President, Student Services
Visit https://www.schooljobs.com/careers/barstowcc to apply.
Sincerely,

Human Resources Office
Barstow College
rpalakiko@barstow.edu
760-252-2411 EXT. 7231
编辑读者评论
内蒙古大学人事处 留言于2019-03-26 10:14:50
评论:UPDATE - From The Chinese American Professors and Professionals Network (2019 No.6)
美国华裔教授专家网

您好,我们是内蒙古大学人事处,我校为实现人才战略大布局,并按学校事业发展需要,决定面向全球招聘高层次人才。特有请贵处协助我校将“2019年面向海内外招聘高层次人才公告”发布在贵处网站相关栏目。非常希望能得到您们的帮助。给您工作上带来的打扰表示歉意并感谢您帮助刊登!

招聘公告链接:http://www.imu.edu.cn/info/1032/1340.htm

内蒙古大学(Inner Mongolia University),是国务院1978年确定的88所全国重点大学之一,是英国《简明大不列颠百科全书》所列中国15所著名大学之一,首批国家“211工程”重点建设的高校。创建于1957年,是新中国成立后在少数民族地区最早创立的一所综合性大学,在国家高等教育布局中具有重要作用和特殊区域定位。2004年成为内蒙古自治区和教育部重点共建大学,2012年入选首批国家“中西部高校综合实力提升工程”高校。有28个省部级重点实验室、工程技术研究中心、人文社会科学重点研究基地。
期待您的回复

内蒙古大学人事处
电话:0471-4992415
ndszk@imu.edu.cn
编辑读者评论
桂林理工大学人事处 留言于2019-03-26 10:09:12
评论:UPDATE - From The Chinese American Professors and Professionals Network (2019 No.6)
美国华裔教授专家网:您好!

我校海外人才引进计划已启动,各个阶段都在大力宣传,因海外渠道有限制,特联系您,希望能够在您的帮助下大力宣传,引导在海外的学者参加此次人才计划,桂林理工正朝向一流学校大步迈进,当然这个过程需要人才。人才是实现民族振兴、赢得国际竞争主动的重要战略资源,

人才能不能留得下、用得好,往往取决于单位发展“格局”的大小,学校在此次招聘中下足了“功夫”,在待遇、福利、绩效等方面各有突出,实现一流人才一流待遇、一流贡献一流报酬。希望海外人才能够来广西发展,见证桂林理工大学的发展、以世界一流高校为目标,共创辉煌!

此项工作希望能够得到您的帮扶,在未来的海外对接工作中同样希望得到您的支持。
期待您的回复

桂林理工大学人事处
0773-2670319
glutedursc@163.com
编辑读者评论
U.S. Food & Drug Administration 留言于2019-03-26 09:55:17
评论:UPDATE - From The Chinese American Professors and Professionals Network (2019 No.6)
The FDA has recently approved the following devices to be marketed (Part 2)

VENTANA PD-L1 (SP142) Assay - P160002/S009
This is a test done in a laboratory using samples from triple negative breast cancer patients which doctors use to see if patients have programmed cell death ligand (PD-L1) in their cancer.

MitraClip NT Clip Delivery System and MitraClip NTR/XTR Clip Delivery System - P100009/S028
The MitraClip NT Clip Delivery System and MitraClip NTR/XTR Clip Delivery System are two newer models of the MitraClip Clip Delivery System approved previously by the FDA. Each system contains a permanent implant that looks and functions like a clip. The clip is used to grasp the two leaflets of the mitral valve in the heart and clip them together to reduce the backflow of blood (called mitral regurgitation or MR). The current application expands the system’s indications for use to include secondary (or functional) MR, when MR is caused by a dysfunctional left ventricle, not by degeneration of the mitral valve itself.

VENOVO Venous Stent System - P180037
The VENOVO Venous Stent System is intended to treat a narrowed vein found in the upper pelvic region down to the groin area (iliofemoral vein). The VENOVO Venous Stent System has two components: a stent made of a nickel-titanium alloy (nitinol) tubing and an over-the-wire stent delivery catheter system.

OPTIMIZER Smart System - P180036
The OPTIMIZER Smart System includes an implantable pulse generator (IPG), a charging system and a programmer. The IPG monitors the heart’s activity and delivers non-excitatory electrical signals (cardiac contractility modulation therapy) to the right ventricle of the heart in patients with chronic heart failure. The charging system is used to recharge the IPG and the programmer to allows medical personnel to control the settings of the device.

COVERA™ Vascular Covered Stent - P170042/S002
The Covera™ Vascular Covered Stent is an expandable, flexible, metal (nitinol) tube-shaped device (stent) that is covered with a material called expanded polytetrafluoroethylene (ePTFE). Each covered stent is mounted on the end of a delivery catheter system. The device was previously approved for use in the treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arterio-venous (AV) access grafts only. In this PMA supplement, FDA approved this device for the treatment of a narrowing (stenosis) or blockage which has developed anywhere in the access circuit of patients on hemodialysis using an Arteriovenous (AV) Fistula.
编辑读者评论
U.S. Food & Drug Administration 留言于2019-03-26 09:50:18
评论:UPDATE - From The Chinese American Professors and Professionals Network (2019 No.6)
The FDA has recently approved the following devices to be marketed (Part1):

Resolute Integrity Zotarolimus Eluting Coronary Stent System - P110013/S088
The Resolute Integrity Zotarolimus Eluting Coronary Stent System is a drug-coated device that contains two components: the stent and the catheter delivery system with a balloon that will inflate to deploy the stent. The stent is placed into a blood vessel (coronary artery) supplying blood to the heart and helps to keep the coronary artery open. The current approval expands the indications for use to include treatment of a blocked coronary artery (chronic total occlusion).

Sangia Total PSA Test - P170037
The Sangia Total Prostate Specific Antigen (PSA) Test consists of a Cassette Assembly and a Sample Collector. The Sangia Total PSA Test is used as an aid in the diagnosis of prostate cancer. This new test is the first point-of-care test that can deliver PSA results near where the patient is being evaluated, for example at the doctor's office, instead of waiting for lab analysis. The test can be administered with a simple finger prick, and results are generated in less than 15 minutes. Prostate-specific antigen, or PSA, is a protein produced by cancerous, as well as noncancerous tissue in the the prostate gland. The PSA test measures the level of PSA in a man's blood.

MANTA Vascular Closure Device - P180025
The MANTA Vascular Closure Device is a system designed to close large puncture sites in one of the large vessels in the leg (femoral artery) following catheterization procedures. The system is a polymer component (toggle) attached to a collagen plug and a delivery system used to place the toggle-collagen plug implant.

M6-C™ Artificial Cervical Disc - P170036
The M6-C™ Artificial Cervical Disc is an implant (device) that replaces the function of a damaged or diseased disc of the neck in the spine (C3-C7). The M6-C™ contains a series of polymer (ultra-high molecular weight polyethylene) fibers wound in a specific pattern. The fiber is wound around a polymer (polycarbonate urethane) core and through the slots in two titanium alloy inner endplates. The two titanium alloy inner endplates are welded to two titanium alloy outer endplates. The endplates attach to the patient's spinal bone and the implant is designed to maintain the natural movement of the spine.

Barricaid® Anular Closure Device (ACD) - P160050
The Barricaid® Anular Closure Device (ACD), also referred to as “Barricaid," is an implant (device) inserted in the spinal bone (vertebrae) of the lower back to try to prevent another herniated discs (reherniation). The Barricaid is made of titanium and is attached to a polyester (polyethylene terephthalate or commonly referred to as PET) flexible woven polymer fabric mesh. The Barricaid is intended to close the hole in a patient's spinal bone (vertebrae) following a limited discectomy procedure in the lower back (L4-S1) after an initial herniated disc.
编辑读者评论
editor@ijrdo.org 留言于2019-03-25 14:53:39
评论:UPDATE - From The Chinese American Professors and Professionals Network (2019 No.6)
IJRDO Journal (https://ijrdo.org/)
editor@ijrdo.org
Call for Paper – March Issue 2019

International Journal for Research in Social Science and Humanities is an open access journal and provide 12 issues in a year. Green Publication is the publisher of this journal and provides many other journals in other fields of research like engineering and technology, medical and pharmaceutical, agricultural research etc. https://ijrdo.org/
Or Submit at the email – editor@ijrdo.org

Deadline of Submission – none
Publication time – at the end of every month
If you want to unsubscribe our journal. Please send a message on-jabbarkh769@gmail.com

Our Journals:-
To join our editorial board, or submit CV with current designation and institution at editor@ijrdo.org
Regards

IJRDO JOURNAL
editor@ijrdo.org
编辑读者评论
【首页】【前页】[21] [22] [23] [24] [25] [26] [27] [28] [29] [30] 【后页】【末页】
第  页  
共12602条留言,每页10条,当前第27/1261页
全部留言读者评论个人留言
您的名字:
电子邮件:
留言题目:
留言内容:
注意: 留言内容不要超过4000字,否则会被截断。
未 审 核:  是
  
CAPPN
CAPPN
我的百宝箱
博客公告
留言簿
论坛回复总汇
我的博友
我的博友日记列表
关于博主
博客名称:美国华裔教授专家网
用户名 :CAPPN
日记总数:
读者评论:12652
访问人次:
网站首页关于我们联系我们申请加入后台管理设为主页加入收藏
美国华裔教授专家网版权所有,谢绝拷贝。如欲选登或发表,请与美国华裔教授专家网联系。
Copyright © 2024 ScholarsUpdate.com. All Rights Reserved.